# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.
Annexon (NASDAQ:ANNX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.35) by 40...
Additional data from the Phase 2 ARCHER trial demonstrating protection of visual acuity and anatomical structure following ANX0...
Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.
Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.
- SEC Filing
Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.
Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and maintains $12 price target.